drugset / Trial / NCT01499069

Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

NCT01499069

NaSingle-groupOpen-labelOther

Summary

Nerve growth factor (NGF), prostaglandin E2 (PGE2)and adenosine triphosphate (ATP) levels in urine were reported to increase in patients with overactive bladder (OAB). Also, administration of the anti-muscarinic agent was reported to decrease urinary NGF and ATP. The investigators aimed to explore the value of the urinary NGF, PGE2 and ATP as biomarker for predicting the treatment responsiveness and symptom relapse in OAB patients. So, the patients can be categorized into responder or non- responder and relapse or non-relapse groups. Ultimately, they can receive individualized treatments.

Timeline

Start
2010-02
Primary completion
2015-11
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fesoterodine Other / unclassified
Subject Oxybutinin Unknown
Subject Propiverin Unknown
Subject Solifenacin Small molecule
Subject Trospium Small molecule

Indications